Abstract:Mortality rates for ovarian cancer have declined only slightly in the past forty years since the “War on Cancer” was declared. The current standard care of ovarian cancer is still cytoredutive surgery followed by several cycles of chemotherapy. The severe adverse effect from chemotherapy drug is a leading cause for the patients to fail in long term therapy post-surgery. New nanocarriers able to minimize the premature drug release in blood circulation while releasing drug on-demand at tumor site have profound impact on the improvement of the efficacy and toxicity profile of the chemotherapeutic drugs. Here we reported a unique type of extremely long tumor retention, multi-responsive boronate crosslinked micelles (BCM) for ovarian cancer therapy. We systemically investigated the stability of BCM in serum and plasma, and their responsiveness to acidic pH and cis-diols (such as mannitol, a safe FDA approved drug for diuresis) through particle size measurement and förster resonance energy transfer (FRET) approach. Paclitaxel (PTX) loaded BCM (BCM-PTX) exhibited higher stability than non-crosslinked micelles (NCM) in the presence of plasma or serum. BCMs possessed a longer in vivo blood circulation time when compared to NCM. Furthermore, BCM could be disassembled in an acidic pH environment or by administrating mannitol, facilitating drug release in an acidic tumor environment and triggered by exogenous stimuli after drug enrichment in tumor mass. Near infra-red fluorescence (NIRF) imaging on SKOV-3 ovarian cancer mouse model demonstrated that the NIR dye DiD encapsulated BCM could preferentially accumulate in tumor site and their tumor retention was very long with still 66% remained on 12th day post injection. DiD-NCM had similar high-level uptake in tumor with DiD-BCM within the first 3 days, its accumulation, however, decreased obviously on 4th day and only 15% dye was left 12 days later. In both formulations, the dye uptake in normal organs was mostly washed away within the first 24–48 h. In in vivo tumor treatment study, PTX loaded BCM showed superior therapeutic efficacy than that of NCM and Taxol. The mice could tolerate 20 mg/kg PTX formulated in nano-formulations, which doubled the maximum tolerated dose (MTD) of Taxol. The administration of mannitol 24 h after BCM-PTX injection further improved the tumor therapeutic effect and elongated the survival time of the mice. The novel boronate-catechol crosslinked nanocarrier platform demonstrated its superior capability in targeted drug delivery, which is not only useful for ovarian cancer treatment but will also be beneficial for the therapy of many other solid tumors.

[Experimental Study of Interstitial Chemotherapy with PYM Delivered from a Solid Implantable Biodegradable Polymer Against Human Tongue SCC in Tumor-Bearing Nude Mice].

Primary study of the tongue squamous cell carcinoma treated with targeting and continuous interstitial chemotherapy

Biodegradable Thermosensitive Hydrogel for Saha and Ddp Delivery: Therapeutic Effects on Oral Squamous Cell Carcinoma Xenografts

Experiment on Lymphatic Chemotherapy of Oral Squamous Carcinoma Using Lymphatic Targeting Dosage Form: Pingyanginycin Absorbed on Activated Carbon Nanoparticles

Integrated Anti-Vascular and Immune-Chemotherapy for Colorectal Carcinoma Using a Ph-Responsive Polymeric Delivery System.

Tumoricidal Effect Of Controlled-Release Polymeric Needle Devices Containing Adriamycin Hcl In Tumor-Bearing Mice

Study of drug distribution in tissue during treatment with targeting and continuous interstitial chemotherapy in the oral squamous cell carcinoma

Chemosensitivity of Tca8113 and BcaCD885 Cell Lines to Cisplatin Loaded Polylactic Acid-polyethylene Glycol Nanoparticles for Targeting Oral Carcinoma.

An injectable adhesive hydrogel for photothermal ablation and antitumor immune activation against bacteria-associated oral squamous cell carcinoma

The Improved Antitumor Efficacy of Continuous Intratumoral Chemotherapy with Cisplatin-Loaded Implants for the Treatment of Sarcoma 180 Tumor-Bearing Mice

Polysulfonium: Unveiling a Bioactive Polymer to Induce Immunogenic Cell Death for Anticancer Therapy

Comprehensive evaluation of biopolymer immune implants for peritoneal metastasis carcinoma therapy

A Polyethylenimine-Modified Carboxyl-Poly(Styrene/Acrylamide) Copolymer Nanosphere for Co-Delivering of Cpg and Tgf-Beta Receptor I Inhibitor with Remarkable Additive Tumor Regression Effect Against Liver Cancer in Mice

[Inhibition Effects of Tumor Necrosis Factor-Alpha Gene Transduced Tumor Drainage Node of Lymphocytes from Tongue Cancer on SCID Mice Transplanted Tumor Established with Human Tongue Carcinoma Cell Lines].

Iontophoresis-Enhanced Buccal Delivery of Cisplatin-Encapsulated Chitosan Nanoparticles for Treating Oral Cancer in a Mouse Model

Chitosan-based liposomal thermogels for the controlled delivery of pingyangmycin: design, optimization and in vitro and in vivo studies

Biodegradable three-dimension micro-device delivering 5-fluorouracil in tumor bearing mice.

Antitumor activity of pingyangmycin against colorectal cancer

The potential for blood vessel engineering of PHSRN-modified polymer: HUVEC cell affinity evaluation and integrin-mediated mechanism study.

Engineered Protein Photo‐Thermal Hydrogels for Outstanding In Situ Tongue Cancer Therapy

Experimental Study of Target-Specific Adriamycin Nanoparticles in Treating Tongue Squamous Cell Carcinoma